Hindenburg Research

Enochian Biosciences Inc. Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Enochian Biosciences Inc. (ENOB)

Retrieved on: 
Friday, August 12, 2022 - 8:36pm

If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .

Key Points: 
  • If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, the price of Enochian's stock fell almost 37%, to close at $3.70 per share on May 25, 2022.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022 - 2:00am

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • For more information on the Coinbase class action go to: https://bespc.com/cases/COIN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 10, 2022 - 6:51pm

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

Retrieved on: 
Saturday, August 6, 2022 - 9:15am

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Enochian Biosciences, Inc. (ENOB) Investors and Encourages Investors to Contact the Firm Before September 26, 2022

Retrieved on: 
Friday, August 5, 2022 - 5:03pm

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the inventor and co-founder of Enochian, had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, the price of Enochian shares declined by $2.17 per share, or approximately 36.9%, from $5.87 per share to close at $3.70 on May 25, 2022.
  • Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

Retrieved on: 
Thursday, August 4, 2022 - 4:00pm

Investors suffering losses on their Enochian investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .

Key Points: 
  • Investors suffering losses on their Enochian investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.
  • On this news, the Companys shares fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

ENOCHIAN BIOSCIENCES, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Enochian Bioscienc

Retrieved on: 
Tuesday, August 2, 2022 - 8:14pm

All investors who purchased the shares of Central District ofCalifornia and incurred losses are advised to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased the shares of Central District ofCalifornia and incurred losses are advised to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
  • You may obtain request additional information concerning the action at www.whafh.com .
  • If you have incurred losses in Enochian Biosciences, Inc. you may, no later than September 26, 2022, request that the Court appoint you lead plaintiff of the proposed class.
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors

Retrieved on: 
Tuesday, August 2, 2022 - 4:45pm

Enochian investors have until September 26, 2022 to file a lead plaintiff motion.

Key Points: 
  • Enochian investors have until September 26, 2022 to file a lead plaintiff motion.
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.
  • On this news, the Companys shares fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Tuesday, August 2, 2022 - 3:10pm

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

Enochian Biosciences, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

Retrieved on: 
Monday, August 1, 2022 - 8:09pm

LOS ANGELES, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB) investors that lost money on their investment to contact attorney Lesley F. Portnoy by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com.

Key Points: 
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder and inventor of Enochian, had been arrested in a murder-for-hire conspiracy.
  • On this news, the Companys shares fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.